Publications by authors named "Peter DeLong"

Claim this Profile
A
A case of tracheal and pulmonary blastomycosis presenting as asymptomatic pulmonary nodules.
Harrison N Agyeman, Devin Lee, William J Hunckler, Peter DeLong, Samuel A Lee

Med Mycol Case Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin.
Anna Biernacka, Konstantinos D Linos, Peter A DeLong, Arief A Suriawinata, Vijayalakshmi Padmanabhan

Cytojournal· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.
Jonathan D Marotti, Mary C Schwab, Nancy J McNulty, James R Rigas, Peter A DeLong

Diagn Cytopathol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical ventilation in the management of acute respiratory distress syndrome.
Peter Delong, James A Murray, Christopher K Cook

Semin Dial· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
Peter DeLong, Richard G Carroll, Adam C Henry, Tomoyuki Tanaka, Sajjad Ahmad

Cancer Biol Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery.
Tomoyuki Tanaka, Peter A Delong, Kunjlata Amin, Adam Henry, Robert Kruklitis

Ann Surg· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
Eiji Suzuki, Veena Kapoor, H Kam Cheung, Leona E Ling, Peter A DeLong

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.
Robert J Kruklitis, Sunil Singhal, Peter Delong, Veena Kapoor, Daniel H Sterman

J Thorac Cardiovasc Surg· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling.
Sunil Singhal, Kunjlata M Amin, Robert Kruklitis, Peter DeLong, Michael E Friscia

Cancer Biol Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta.
Omar Tliba, Samira Tliba, Chien Da Huang, Rebecca K Hoffman, Peter DeLong

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.
Peter DeLong, Tomoyuki Tanaka, Robb Kruklitis, Adam C Henry, Veena Kapoor

Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy.
Makoto Odaka, Rainer Wiewrodt, Peter DeLong, Tomoyuki Tanaka, Yi Zhang

Mol Ther· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis